North America Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application (Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry), By Country and Gro

North America Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application (Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry), By Country and Growth Forecast, 2022 - 2028

The North America Protein Labeling Market would witness market growth of 6.9% CAGR during the forecast period (2022-2028).

Advanced imaging techniques can provide extensive information on the spatial and temporal structure of individual proteins, along with information on conformational dynamics and interactions. Although, as imaging techniques improve, the accuracy with which (optical) probes can be affixed to proteins in their original context limits the amount of information that can be gathered about protein activity in cells. Current protein-labeling methods include fluorescent protein fusions, self-labeling proteins, ligases, and self-labeling tags. Although several of these methods allow for quick labeling and have had a significant impact on developmental biology, it necessitates the use of protein fusions and/or the addition of extra sequences to the protein of interest.

Intein-mediated protein ligation (IPL) or expressed protein ligation are two more methods for labeling proteins. Through a natural peptide bond, the IPL reaction allows a synthetic peptide or protein with an N-terminal cysteine residue to binding to the thioester on the C-terminus of an expressed protein. To produce and purify a protein of interest and synthesize a thioester at its C-terminus, the IPL procedure uses an IMPACTTM C-terminal fusion vector. Peptides that may contain changed amino acids or proteins can be ligated to the C-terminus of an IMPACT-produced protein using IPL.

The regional government is bringing several relevant guides for medical institutions and infrastructure in order to successfully implement advanced technology like protein labeling in the healthcare market. The new edition of Canada's Food Guide, provided new guidelines by grouping meat and substitutes with milk and replacements into a single category named "protein foods," emphasizing the importance of eating more plant-based foods from this area. Despite the fact that the revisions constitute a basic picture of a nutritious plate, the new Food Guide has revealed fresh issues about the understanding and execution of the Food Guide among vulnerable populations, such as youngsters and the elderly.

Families with young children are a particular target for such resources within consumers, as this creates life-long habits to guarantee people have the experience and abilities to choose, produce, and ingest nutrient-rich protein foods. The new Food Guide offers a chance to fill knowledge gaps, develop tools and resources to assist health professionals, and devise interventions to assist Canadian families in selecting, preparing, and eating nutrient-rich protein meals. Novelty Protein labeling and content/health claims in Canada require a new regulatory framework. To ensure the provision of high-quality protein diets throughout institutions that serve children and older individuals, mandatory nutrition rules are required. Therefore, due to increased efforts made by the regional government, the protein labeling market is expected to grow in the forecast period.

The US market dominated the North America Protein Labeling Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $937.5 million by 2028. The Canada market is experiencing a CAGR of 9.3% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 8.4% during (2022 - 2028).

Based on Method, the market is segmented into In-vitro (Enzymatic, Dye-based, Co-translational, Site-specific, Nanoparticle, and Others) and In-vivo (Photoreactive, Radioactive, and Others). Based on Product, the market is segmented into Reagents, Kits, and Services. Based on Application, the market is segmented into Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, PerkinElmer, Inc., General Electric (GE) Co., F. Hoffmann-La Roche Ltd., Kaneka Corporation, New England BioLabs Inc., Promega Corporation, LI-COR, Inc., and SeraCare Life Sciences.

Scope of the Study

Market Segments covered in the Report:

By Method

• In-vitro
• Enzymatic
• Dye-based
• Co-translational
• Site-specific
• Nanoparticle
• Others
• In-vivo
• Photoreactive
• Radioactive
• Others

• Reagents
• Kits
• Services

• Immunological Techniques
• Cell-based Assays
• Fluorescence Microscopy
• Protein Microarray
• Mass Spectrometry

• US
• Canada
• Mexico
• Rest of North America

• Thermo Fisher Scientific, Inc.
• Merck Group
• PerkinElmer, Inc.
• General Electric (GE) Co.
• F. Hoffmann-La Roche Ltd.
• Kaneka Corporation
• New England BioLabs Inc.
• Promega Corporation
• LI-COR, Inc.
• SeraCare Life Sciences

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free